The vision for the Trinity Translational Medicine Institute is
“Driven by the need to move from knowledge for the sake of knowledge to knowledge that realises human benefit”
Professor Orla Sheils, Director
Translational medicine is the prevailing paradigm, stemming from evidence-based medicine with the integration of basic and clinical research to advance human health.
As an exclusively health sciences-focused educational and research institution, embedded within the acute hospital setting, TTMI is uniquely placed to develop and enhance translational research for the benefit of patients and to improve the health of the community. TTMI’s thematic research priorities reflect the wide diversity of healthcare facilities and needs, locally and nationally.
More
As an exclusively health sciences-focused educational and research institution, embedded within the acute hospital setting, TTMI is uniquely placed to develop and enhance translational research for the benefit of patients and to improve the health of the community. TTMI’s thematic research priorities reflect the wide diversity of healthcare facilities and needs, locally and nationally.
Latest News
-
Primary School Outreach Event -
Latest TTMI Newsletter
-
Post Doc Position available in Cancer Biotherapeutics
-
CRF and TTMI to jointly host Symposium on Public and patient Involvement in Research to Celebrate International Clinical Trials Day
-
TTMI Officially Opened on 31st March ‘17
-
TTMI Allergan Innovation Award - €8,500
-
Building Engagements in Health Research - Pilot Scheme 2017
-
Industry-funded Post-Doc. position available for 6 months (in the first instance). Ideally starting on 1st Feb, but no later than 1st March. The individual must have experience of cell culture, immunoblotting and use of standard bio-lab. equipment including centrifugation/ultracentrifugation. S/he must also be competent in storing, analysing and reporting on data generated. If you or anyone you know of -from within TCD or outside- may be interested, please ask them to send a copy of their CV to: Prof. Lorraine O'Driscoll
Professor in Pharmacology
lodrisc@tcd.ie -
Coming soon Internal competition for funding for pilot projects. Must involve collaboration between clinical and basic science TTMI researchers. Full details available soon.
TTMI Official Launch Date 31st March 2017. Watch this space for further details of programme
Welcome to the new Ussher Assistant Professors that are affiliated to TTMI Adriele Prino Mello, Dr. Shigeki Nakagome and Dr. Stephen Maher -
Vacancies - Research Fellow in Molecular OncologyResearch Fellow in Molecular Oncology
-
Research OpportunitiesThe Irish Cancer Society Research Scholarship Programme 2017 is now open for applications -
ICAT is an exciting new all Ireland clinician PhD programmeFunded by Wellcome and the Health Research Board, HSE-NDTP; HSC R&D Division; and six Universities; TCD, UCD, NUIG, QUB, RCSI and UCC. The programme is coordinated by Molecular Medicine Ireland.
Integrated with postgraduate medical training, ICAT will support 4 years of academic training at the beginning of higher specialist training (HST) or equivalent, with clinical and academic mentoring until completion of PhD and CCST/CCT.
ICAT now seeks to appoint the first cohort of 8 well qualified and ambitious medical graduates who aspire to become the next generation of clinical academic leaders. -
Inaugural Lecture in the TTMI Immunology Seminar Series14th September 1pm in the Dorothy Stopford Price Theatre. The guest speaker will be Renate Kain, Professor of Pathology, Autoantibodies to LAMP-2 - modulators of the immune response?
Our Partners
The School of Medicine
Trinity College Dublin
Trinity Health Ireland
Tallaght Hospital
St James's Hospital
Coombe Women and Infants University Hospital